NEW YORK (GenomeWeb News) – BioTime said yesterday that its Embryome Sciences subsidiary has inked a manufacturing and distribution deal with Lifeline Cell Technology, a subsidiary of International Stem Cell.
The partners intend to manufacture cell lines and supplies that scientists will use in stem cell research for regenerative medicine and drug discovery. They said the progenitor cell lines will be produced and distributed jointly using Emryome Sciences’ Embryonics technology, International Stem Cell’s parthenogenetic stem cell lines derived from unfertilized human eggs, and technology and approved hES cell lines licensed from the Wisconsin Alumni Research Foundation.
Data from the cell lines will be presented on Embryome Sciences’ future Embryome.com online database, Alameda, Calif.-based BioTime said. International Stem Cell also will contribute manufacturing and quality-control expertise.
Financial terms of the alliance were not disclosed.